Brevan Howard Capital Management LP Tg Therapeutics, Inc. Transaction History
Brevan Howard Capital Management LP
- $17 Billion
- Q3 2025
A detailed history of Brevan Howard Capital Management LP transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 18,355 shares of TGTX stock, worth $569,005. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,355
Previous 60,120
69.47%
Holding current value
$569,005
Previous $2.16 Million
69.35%
% of portfolio
0.0%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding TGTX
# of Institutions
395Shares Held
90.5MCall Options Held
1.77MPut Options Held
1.9M-
Vanguard Group Inc Valley Forge, PA15.5MShares$481 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$353 Million0.0% of portfolio
-
State Street Corp Boston, MA8.1MShares$251 Million0.01% of portfolio
-
Clearbridge Investments, LLC New York, NY4.64MShares$144 Million0.13% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.84MShares$119 Million8.45% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.5B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...